Search results
Results from the WOW.Com Content Network
Prohibitin-targeting peptide 1 (also known as prohibitin-TP01 and TP01; trade name Adipotide) is a peptidomimetic with sequence CKGGRAKDC-GG-D (KLAKLAK) 2. It is an experimental proapoptotic drug [ 1 ] that has been shown to cause rapid weight loss in mice [ 2 ] and rhesus monkeys. [ 3 ]
A peptidomimetic is a small protein-like chain designed to mimic a peptide. [ 1 ] [ 2 ] They typically arise either from modification of an existing peptide, or by designing similar systems that mimic peptides, such as peptoids and β-peptides .
Peptoids (root from the Greek πεπτός, peptós "digested"; derived from πέσσειν, péssein "to digest" and the Greek-derived suffix -oid meaning "like, like that of, thing like a _____," ), or poly-N-substituted glycines, are a class of biochemicals known as biomimetics that replicate the behavior of biological molecules. [1]
6564 56643 Ensembl ENSG00000088386 ENSMUSG00000025557 UniProt P46059 Q9JIP7 RefSeq (mRNA) NM_005073 NM_053079 RefSeq (protein) NP_005064 NP_444309 Location (UCSC) Chr 13: 98.68 – 98.75 Mb Chr 14: 121.7 – 121.74 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse PepT 1 is a proton-coupled peptide cotransporter in epithelial cells. Peptide transporter 1 (PepT 1) also known as solute ...
The Nurses' Health Study 1 contained populations representing nurses of the time, but did not reflect great diversity. The participants had a slightly higher income than the average of the time and a majority were white (97%). [5] In 2012, however, minority participants were increasingly sought after. [40]
Hence, inhibition of the HIV protease is one of the most important approaches for the therapeutic intervention in HIV infection [2] and their development is regarded as major success of structure-based drug design. [3] They are highly effective against HIV [4] and have, since the 1990s, been a key component of anti-retroviral therapies for HIV ...
Strattera is the first drug to mention the test in the official documentation, although it doesn't specifically recommend that patients get the test before taking the medication. There are four possible categories for each marker: poor metabolizer , intermediate metabolizer , extensive metabolizer , or ultra-extensive metabolizer .
Beta-secretase 1, also known as beta-site amyloid precursor protein cleaving enzyme 1, beta-site APP cleaving enzyme 1 (BACE1), membrane-associated aspartic protease 2, memapsin-2, aspartyl protease 2, and ASP2, is an enzyme that in humans is encoded by the BACE1 gene. [5] Expression of BACE1 is observed mainly in neurons and oligodendrocytes. [6]